Cargando…

Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report

Beta-blockers are well-known for their wide range of therapeutic applications, particularly in patients with cardiac diseases. Physicians worldwide are aware of their potential side effects, including hypoglycemia, dizziness, slow heart rate, fatigue, and heart block. We report a case of erythroderm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voloshyna, Diana, Ehsan Ullah, Saad, Jahan, Nusrat, Yadlapalli, Sai Sreya, Zahoor, Mohammad Munim, Shams, Yumna, Sathish, Meenakshi, Sandhu, Qudsia I, Saleem, Farhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Dermatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621099/ https://www.ncbi.nlm.nih.gov/pubmed/36337823 http://dx.doi.org/10.7759/cureus.29809

Ejemplares similares

Erythrodermic Psoriasis Exacerbated by Bupropion
por: Foss, Michael G, et al.
Publicado: (2021)

Distributive Shock in Erythrodermic Psoriasis Treated With Norepinephrine and Vasopressin: A Case Report
por: Karimi, Mehrdad, et al.
Publicado: (2023)

Low-dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis
por: Beltran Monasterio, Eduardo P
Publicado: (2019)

An Uncommon Presentation of Erythrodermic Psoriasis in a Patient Without a History of Psoriasis
por: Rendo, Matt, et al.
Publicado: (2019)

Erythrodermic Psoriasis in a Man with Monoclonal B-cell Lymphocytosis
por: Chen, Stella X, et al.
Publicado: (2017)

An Erythrodermic Psoriasis Flare-Up With Staphylococcus Bacteremia Secondary to COVID-19 Infection: A Case Report
por: Ali Khan, Qaisar, et al.
Publicado: (2023)

Mechanisms of Beta-Blocker Induced Psoriasis, and Psoriasis De Novo at the Cellular Level
por: Awad, Vanessa M, et al.
Publicado: (2020)

The Co-Existence of Agranulocytosis and Stevens-Johnson Syndrome (SJS) in Carbamazepine Therapy: A Case Report
por: Batool, Saima, et al.
Publicado: (2022)

Tinea Corporis-associated Erythroderma: Case Report and Review of Erythrodermic Patients with Chronic Dermatophyte Infection
por: Yousefian, Faraz, et al.
Publicado: (2020)

Erythrodermic Psoriasis Treated with Apremilast
por: Arcilla, John, et al.
Publicado: (2016)

Treatment of erythrodermic psoriasis with apremilast
por: Gioe, Olivia A., et al.
Publicado: (2021)

Updates on the Treatment of Erythrodermic Psoriasis
por: Lo, Yang, et al.
Publicado: (2021)

Erythrodermic Psoriasis Managed with Risankizumab
por: Alajlan, Abdulmajeed, et al.
Publicado: (2022)

Erythrodermic psoriasis improved by Tildrakizumab
por: Trevisan, Giampaolo, et al.
Publicado: (2022)

A Rare Presentation of Isolated IgM Deficiency in a 28-Year-Old Male: A Case Report
por: Voloshyna, Diana, et al.
Publicado: (2022)

Coexistence of Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma in a Renal Transplant Recipient: A Case Report
por: Voloshyna, Diana, et al.
Publicado: (2022)

Erythrodermic psoriasis after discontinuation of ixekizumab
por: Potter, Kathryn Anne, et al.
Publicado: (2017)

The Management of Erythrodermic Psoriasis Complicated by Cyclosporine
por: Rao, Suman, et al.
Publicado: (2020)

Organizing Pneumonia Complicated with Erythrodermic Psoriasis
por: Nakamura, Hiroyuki, et al.
Publicado: (2019)

An Unusual Presentation of Esophageal Tuberculosis: A Case Report
por: Zahra, Tafseer, et al.
Publicado: (2022)

Warfarin-Induced Skin Necrosis in a 14-Year-Old Female: A Case Report
por: Zahra, Tafseer, et al.
Publicado: (2022)

Erythrodermic psoriasis: pathophysiology and current treatment perspectives
por: Singh, Rasnik K, et al.
Publicado: (2016)

Respiratory Distress Syndrome Associated with Erythrodermic Psoriasis
por: Noure, Lamya, et al.
Publicado: (2021)

Erythroderme Psoriasis nach COVID-19-Erkrankung
por: Demiri, Jeta, et al.
Publicado: (2022)

Erythroderme Psoriasis nach COVID-19-Erkrankung
por: Demiri, Jeta, et al.
Publicado: (2021)

Erythrodermic psoriasis after COVID-19 vaccination
por: Trepanowski, Nicole, et al.
Publicado: (2022)

Two cases of Erythrodermic psoriasis treated with Golimumab
por: Kudsi, Mayssoun, et al.
Publicado: (2022)

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
por: Potestio, Luca, et al.
Publicado: (2023)

Hyperpigmentation as a Primary Symptom of Vitamin B12 Deficiency: A Case Report
por: Jangda, Anzal, et al.
Publicado: (2022)

Hidradenocarcinoma of the Left Knee in a 55-Year-Old Woman: A Case Report
por: Ghaffari, Muhammad Abu Zar, et al.
Publicado: (2022)

The Treatment of Psoriasis
Publicado: (1908)

Erythrodermic Psoriasis Treated with Golimumab: A Case Report
por: Lee, Won-Ku, et al.
Publicado: (2015)

Erythrodermic presentation of psoriasis in a patient treated with dupilumab
por: Tracey, Elisabeth H., et al.
Publicado: (2018)

Erythrodermic Psoriasis Causing Uric Acid Crystal Nephropathy
por: Ellis, John, et al.
Publicado: (2019)

Erythrodermic psoriasis in post-coronavirus disease 2019 patient
por: Batubara, Irwan Saputra, et al.
Publicado: (2022)

Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?
por: Megna, Matteo, et al.
Publicado: (2021)

A case of erythrodermic psoriasis successfully treated with apremilast
por: Megna, Matteo, et al.
Publicado: (2021)

FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic Review
por: Aslam, Nida, et al.
Publicado: (2020)

Out of the Blue: A Case of Blue Subungual Discoloration Associated with Prolonged Tetracycline Use
por: Ahmad, Yumna, et al.
Publicado: (2020)

Perforating Granuloma Annulare Mimicking Psoriasis
por: Jacob, Joanne S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b22pa351euah8k4g6fd90denqp